United States · FDA National Drug Code directory
Guaifenesin D
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0536-1333_5123ee03-a227-4e51-e063-6294a90ab1a0
- Product NDC
- 0536-1333
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guaifenesin and Pseudoephedrine Hydrochloride
- Labeler
- RUGBY LABORATORIES, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220404 / 20270331
Source-listed ingredients
- GUAIFENESIN — 600 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (0536-1333-21) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 0536-1333-21
- 2 BLISTER PACK in 1 CARTON (0536-1333-36) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 0536-1333-36
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →